NYSE:OWLTMedical Equipment
Owlet (OWLT): Valuation Check After New 1 Natural Way Partnership Expands BabySat Insurance Access
Owlet (OWLT) is back on traders’ screens after announcing a new DME partnership with 1 Natural Way, opening insurance backed access to its FDA cleared BabySat monitor for higher risk infants nationwide.
See our latest analysis for Owlet.
The DME deal lands after a busy stretch that included the UK and Ireland rollout of Owlet360 and a recent shelf registration closing. The market seems to be reassessing the story, with the share price at $14.05 and a powerful year to date share price return...